Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Fatigue 6 Pain 4 Anxiety Disorders 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Hematologic Neoplasms 2 Genital Neoplasms, Female 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vomiting 1 Vaginal Neoplasms 1 Signs and Symptoms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peripheral Nervous System Diseases 1 Nausea 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Fatigue Syndrome, Chronic 1 Epilepsy 1 Endometrial Neoplasms 1 Depression 1 Congenital Abnormalities 1 Caregiver Burden 1 Cancer Pain 1

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Medical Marijuana 2 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Topotecan 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Epilepsy × Therapeutic Touch × Clear all

NCT04152109 2024-05-08

PICS

Universidade Federal do Triangulo Mineiro

Phase NA Unknown

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡